Accuray Inc (ARAY)
1.62
+0.08
(+5.19%)
USD |
NASDAQ |
May 03, 16:00
1.63
+0.01
(+0.62%)
After-Hours: 20:00
Accuray Price: 1.62 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 1.60 | 1.62 | 1.54 | 1.62 | 1.523M |
May 02, 2024 | 1.82 | 1.83 | 1.51 | 1.54 | 5.309M |
May 01, 2024 | 2.15 | 2.21 | 2.14 | 2.17 | 626664.0 |
Apr 30, 2024 | 2.18 | 2.18 | 2.12 | 2.13 | 455945.0 |
Apr 29, 2024 | 2.20 | 2.22 | 2.17 | 2.22 | 452317.0 |
Apr 26, 2024 | 2.20 | 2.23 | 2.16 | 2.19 | 344340.0 |
Apr 25, 2024 | 2.18 | 2.21 | 2.14 | 2.18 | 359341.0 |
Apr 24, 2024 | 2.21 | 2.225 | 2.16 | 2.20 | 293900.0 |
Apr 23, 2024 | 2.18 | 2.25 | 2.17 | 2.22 | 414401.0 |
Apr 22, 2024 | 2.15 | 2.19 | 2.10 | 2.17 | 1.250M |
Apr 19, 2024 | 2.18 | 2.22 | 2.10 | 2.14 | 634097.0 |
Apr 18, 2024 | 2.22 | 2.246 | 2.17 | 2.21 | 693509.0 |
Apr 17, 2024 | 2.24 | 2.25 | 2.17 | 2.19 | 464383.0 |
Apr 16, 2024 | 2.30 | 2.30 | 2.23 | 2.23 | 382640.0 |
Apr 15, 2024 | 2.30 | 2.33 | 2.22 | 2.31 | 764648.0 |
Apr 12, 2024 | 2.35 | 2.36 | 2.27 | 2.28 | 429776.0 |
Apr 11, 2024 | 2.39 | 2.39 | 2.315 | 2.34 | 478576.0 |
Apr 10, 2024 | 2.38 | 2.419 | 2.33 | 2.37 | 675967.0 |
Apr 09, 2024 | 2.42 | 2.42 | 2.38 | 2.41 | 466954.0 |
Apr 08, 2024 | 2.42 | 2.42 | 2.38 | 2.40 | 414888.0 |
Apr 05, 2024 | 2.41 | 2.425 | 2.39 | 2.40 | 342171.0 |
Apr 04, 2024 | 2.43 | 2.52 | 2.40 | 2.41 | 355142.0 |
Apr 03, 2024 | 2.42 | 2.47 | 2.40 | 2.40 | 286971.0 |
Apr 02, 2024 | 2.35 | 2.45 | 2.330 | 2.43 | 455189.0 |
Apr 01, 2024 | 2.47 | 2.48 | 2.37 | 2.41 | 489026.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.35
Minimum
Mar 24 2020
5.89
Maximum
Feb 09 2021
3.217
Average
2.91
Median
Sep 26 2019
Price Benchmarks
Boston Scientific Corp | 72.85 |
Integer Holdings Corp | 111.27 |
ResMed Inc | 216.98 |
Glaukos Corp | 106.51 |
Perspective Therapeutics Inc | 1.81 |
Price Related Metrics
PS Ratio | 0.3509 |
PEG Ratio | -0.702 |
Price to Book Value | 3.371 |
Price to Free Cash Flow | 20.64 |
Earnings Yield | -9.26% |
Market Cap | 160.65M |
PEGY Ratio | -0.702 |
Operating PE Ratio | 1453.97 |